Finally, chronic inflammation within the tumor niche leads MM-MSCs to activate TLR4 signaling, which polarizes them toward a pro-tumorigenic phenotype, favoring immunosuppression and tumor growth [7]. Here, TLR4 is linked to neoplasm.